Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

Angiology

Volumn 35, Issue 12, 1984, Pages 773-778

  Krauss, Shimon ^a   Spitz, Edward ^a   Krauss, Agota ^a   Grizotzki, Bronja ^a   Clement, Sinai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; SALBUTAMOL;

ASTHMA; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DRUG THERAPY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RESPIRATORY SYSTEM; THERAPY;

ADULT; ALBUTEROL; ASTHMA; ATENOLOL; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE;

EID: 0021713354     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/000331978403501204     Document Type: Article

References (20)

1. Decalmer Pbs, et al: Beta-blockers and asthma. Brit Heart J 40: 184-189, 1978.
2. Ellis ME, et al: Cardioselectivity in asthmatic patients. Eur J Clin Pharmacol 21: 173-176, 1981.
3. McLeod AA, et al: Differentiation of hemodynamic humoral and metabolic responses to B, and B2 adrenergic stimulation in men using Atenolol and propranolol. Circulation 67: 1076-1084, 1983.
4. Study group on exercise challenge, bronchoprovocation committee. American Academy of Allergy. Guidelines for the methodology of exercise challenge testing of asthmatics. J Allerg Clin Immunol 64: 642-648, 1979.
5. Trautlein JJ: Risk factors in exercise testing. J Allergy Clin Immunol 64: 625-626, 1979.
6. Lehman EL, Abrera HJ: Non-parametrics. Holden-Day Inc, McGraw Hill, Intern Book Company, San Francisco, 1975.
7. Tukey JW: Exploratory data analysis. Addison-Wesley Publ Co, Massachusetts, 1977.
8. Mallion JM, et al: Interet de l'etude a l'effort chez normotendu et ches l'hypertendu des chifre de la pression arterielle. Arch Mal Coeur 68: 1001-1009, 1975.
9. Astrom H., Vallin H.: Effect of a new beta-adrenergic blocking agent i.c.i. 66082 on exercise hemodynamics and airway resistance in angina pectoris. Brit Heart J 36: 1194-1200, 1974.
10. Cruickshank JM: The clinical importance of cardioselectivity and lipophilicity in beta-blockers. Am Heart J 100: 160-178, 1980.
11. Amery A., et al: Relationship between blood level of Atenolol and pharmacologic effect. Clin Pharm Therap 21: 691-699, 1977.
12. Gribbin HR, et al: Bronchial and cardiac beta-adrenoceptor blockade. A comparison of Atenolol, Acebutol and Labetamol. Br J Clin Pharmacol 12: 61-65, 1981.
13. Taylor EA, Trembath PW, Warrington SJ: Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoreceptor antagonists in man. Br J Clin Pharmac 12: 201-209, 1981.
14. Leenen Fhh, et al: Effects of cardioselective and non-selective beta-blockade on dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther 28: 12-21, 1980.
15. Maistrello J.: Hypertensive patients treated with Atenolol. Drugs 25: 69-71, 1983.
16. Mohsen Ibrahim, Ragaa Mossallam: Clinical evaluation of Atenolol in hypertensive patients. Circulation 64: 368-379, 1981.
17. Vilsvik JS, Schanning J.: Effect of Atenolol on ventilatory and cardiac function in asthma. Brit Med J 2: 453-455, 1976.
18. Freis ED, Materson BJ, Flamenbaum W.: Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. Am J Med 74: 1029-1041, 1983.
19. McNeill RS: Effect of a beta-adrenergic blocking agent - propranolol - on asthmatics. Lancet 2: 1101-1107, 1964.
20. Palmer Knv: Respiratory side effects of beta-blockers (letter). Br Med J 1: 840, 1977.